Janssen Biotech's proposed purchase of a Maryland biopharm firm could top $1B

The Johnson & Johnson subsidiary declined to disclose the purchase price. The company being acquired provided the details.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.